Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If I’m correct, I won’t need the gift card!!
I was looking at the same thing and then it hit me, the $ is right next to the % key on a standard keyboard. When I was researching typical tech royalty fees I found that a typical fee is 5% of the gross sales figures. So, if (1) Samsung had gross annual sales in the $200B range for the last five years, and (2) Hong is correct that netlist was incorporated into 80% of Samsung products, the settlement could be valued around $48 billion. Before treble damages. At around a quarter billion shares in circulation that puts the potential basic settlement value at around $192/share. Plus google. Plus micron.
So if Hong is in the right ballpark and Samsung has incorporated netlist technology in around 80% of their products, that is 80% of a rough average of $200B in sales per year for the last 10 years. A quick google (no pun intended) search reveals that technology licensing is typically 5% of gross sales. Over 10 years this is 5% of 1.6Trillion, or about $80 Billion. Which at around 250 million shares outstanding works out to roughly $320/share. Before treble damages. Back of the envelope math. Not counting google. Not counting Micron. Just sayin. Let’s settle for half.
It’s coming, and sooner rather than later.
This will become a positive feedback loop as the volume increases and the price explodes. My sticky note projections for each days closing prices that I write down mid-afternoon each day have been consistently exceeded each day, this has to start getting big attention soon. Then a potential investor does a cursory search and realizes how huge this can get, and he’s in. Rinse and repeat. This hit around $10 with little court activity. I’m guessing 10x that when the legal fireworks really start.
Very interesting. Being that filing a document with the court is a deliberate act, one has to question whether this is a true mistake, a way of signaling intent to the other side, or just psy-ops.
The withdrawal of objections looks like a step in ongoing negotiations. They want something, so they give something. The objections may have been legitimate concerns when originally presented, or may have been part of a pile of stuff to bury the defense in legal gymnastics. Either way, these particular items were low enough on the priorities to be given up. Let’s hope they got something worthwhile in exchange. I also agree that it does no good to be at war with customers. A settlement needs to be reached that is significant, that properly compensates netlist for the theft of their intellectual property, that validates the legitimacy of patent law, and that does not do structural damage to Samsung, Google or Micron.
Interesting - I just completed a transaction where I purchased USDT on coinbase this morning. Not sure why they are flagging it on your account.
As far as the question on Android vs iPhone, I am not familiar with any of the Android stuff, I would imagine it would be about the same though.
How to buy Safemoon on BitMart.
If you are going to do this, understand the basic sequence first, then go to a quiet place where you can work without distractions or interruptions. Do not do this someplace where you can not pay attention to every step. If you make a mistake, there is a chance you will lose all of your money.
THIS IS NOT FINANCIAL ADVICE. BUYING SAFEMOON CAN CAUSE YOU TO LOSE ALL OF YOUR MONEY. MAKE YOUR OWN DECISIONS, DO YOUR OWN RESEARCH, AND PROCEED AT YOUR OWN RISK.
This is all done on an Apple Iphone and the apps available on that platform.
To buy Safemoon on Bitmart you will need to transfer some cryptocurrency to BitMart so you can use that to buy it. The cryptocurrency that I have used to do this is Tether (USDT). You can buy USDT on a currency exchange like Coinbase. If you buy it on Coinbase using a bank draw, Coinbase will usually make you wait 7 to 14 days to withdraw it while they wait for the money to clear. They offer no explanation for this, it’s just the way it is. You can buy and move Bitcoin, Ethereum, or any other coin as well. The reason I use USDT is that it is stable in price. If you buy $100 of USDT, it will still be worth $100 in a week or a month. If you buy Bitcoin or Ethereum, it will move with the market. Sometimes this is good, sometimes you will lose half of your money by the time it clears. Make your own decisions.
So, to buy USDT on Coinbase, look on the bottom of the app, there are five buttons, click either Portfolio or Prices, and scroll down to Tether. It will say USDT as well. Click on this, and click the “Trade” button. Scroll down if the button is not visible, it should be there. Fund the purchase with whatever payment method you’ve set up, and select the amount you want to buy, and purchase it.
You have just completed the first step.
Wait for the Tether to be clear to send, then proceed to the next step.
To move USDT from Coinbase to BitMart (assuming you have already set up accounts on each platform), open both Apps on your phone. Go to BitMart, look on the bottom menu, on the far right is a button labeled “Assets”. Open that tab. Scroll down until you find USDT. Click on it. There will be three buttons shown, Deposit, Withdraw and Trade. If you have no Tether in BitMart the Trade button will be a bit dim, it won’t be active. Don’t worry about that. Click on the Deposit button. At the top, just under the label of USDT but above the QR code there will be four tabs, and above them it will be asking you to “select chain”. Select ERC20. This is the chain that Coinbase uses.
IF YOU SELECT THE WRONG CHAIN, YOUR MONEY WILL BE GONE. IT WILL VANISH WITHOUT A TRACE AND BE UNRECOVERABLE.
Once you select ERC20, see just below, there will be an address that looks like alphabet soup. Click the Copy button to the right of the address. This is where you are sending your money.
Now, minimize BitMart on your phone, and go to Coinbase. Within Coinbase, there are five buttons on the bottom, click on the Portfolio button. Scroll down until you see Tether, it will show your balance as well. Click on Tether, and it will go to the next screen. Below the graph of the price there is a button that says USDT Wallet. Click on that button. It will open a new screen. At the top, on the right there are two circles, one has a QR code symbol in it, the other is an arrow. Click on the arrow button. That button gets you to the “send” menu for your USDT. The next screen says “enter amount”. You can either enter a specific amount, or click the “max” button to the left of where the amount is displayed. This will then display how much you want to send. Once this is done, click the “Continue” button on the bottom of the page. It will open a new screen that asks you for the address you are sending it to. Click on that box and paste in the address that you copied from BitMart. Below that is a box that allows you to enter any notes you might want to. It’s up to you. Then click “send”, and it will be on its way. Coinbase usually makes you enter a code that it sends to your phone to ensure it’s really you requesting the transaction – no big deal, just enter the code and it will go through. You can close Coinbase now.
The “send” transaction may take 10 to 30 minutes depending on traffic.
Go back to BitMart and check under the “Assets” tab to see when your USDT has arrived. Once it has arrived, you can use it as currency to buy SafeMoon. Go to the Assets tab on the bottom of the screen, scroll down until you find “Safemoon”, and click on it. Once it is open, at the top just under the price are the “buy” and “sell” buttons. Click on the “buy” button, and enter your bid price under “limit order”. Below that is a “quantity” that you will need to fill in. They make it easy, just under the quantity fill in section are four tabs for 25%, 50%, 75 and 100%. I am usually just buying this, I click on the 100% button and it fills in the maximum quantity I can buy for my bid price. Then hit the “buy” button. The order will show up at the bottom under “open orders” until it fills.
If you click “buy” and there is nothing below, your order has filled. Go back to “assets” by clicking the “back” arrow in the upper left corner, it will show your balance of Safemoon.
Done.
Just curious, where are you hearing this? It would be great for the Safemoon community, just looking for source of information so I can verify before I cross post to twitter and Reddit.
I consider the "reflections" from sales to be a nice thing to get, but I'm not counting on them as a source of significant income. My holdings are "enough" by my measure, to provide for some nice returns as the price builds - maybe the extras earned through reflections will eventually pay the 10% penalty when I sell.
I was looking for a crypto project that was
(a) early in it's lifespan,
(b) far enough along to be beyond the 3 day rug pull scam phase, and
(c) able to be had for a low price with room for appreciation.
Safemoon checked all of the boxes for me.
In my experience it was moderate to extremely difficult to buy (I'm fairly new in the crypto world, this made me go off the beaten path).
It is actively building brand recognition, and making easier purchase channels available. I think if they continue on the path they are on, building brand equity and easing barriers to entry, this can do very well this year.
I do like the relative stability of the price as well, the increases are slow and steady, no spikes and drops. I think if it does not "pop" by the end of the summer we may need to sit on it for another few years until the crypto bull cycle repeats itself. I hope for sooner, but can wait for later.
I have seen that claim as well, I have not seen anyone state otherwise.
I tend to just look at their website for that particular metric, I follow them on twitter but it's not my platform of choice, too much noise. Reddit is another story entirely as well.
Either way, they have seen tremendous growth since inception, and the relatively steady price is a welcome aspect of a crypto. The 10% penalty does seem to work to prevent folks from day trading it for the most part.
I'm seeing 2,248,453 on their website home page. Two weeks ago it was 1,800,000, great growth in a short amount of time.
Based on what? Believe me, I'm with you, just looking for a basis of this prediction.
You buy safemoon using USDT as the purchase currency. Go to the "assets" tab on the bottom if you're using the app, then find SAFEMOON. Click on it, there will be a button for "TRADE". Click that, then click "BUY" up top, just under the streaming quote. Limit order, put in your upper limit price, then how many tokens you want to buy, then hit the "buy" button. Pretty straightforward.
Semantics. You’re right, I’m wrong. The substance of my opinion stands as my opinion. Feel free to disagree, I really don’t care.
The significance of legislation on the success of this device is that without legislation, the acceptance criteria for driving on the roads or operating heavy equipment at work (for example) is zero. There can be no THC in the subject person’s system. Because it is difficult to measure THC without a blood draw (in the absence of a workable THC breathalyzer), workplaces use urine tests or follicle testing that looks for metabolites of THC to see if the subject person used them at all in the past (x) number of days.
Now add legislation that legalizes THC use. Because it (or at least it’s metabolites) stick around for some time, instead of zero there must be a new level established, below which it is generally agreed by the courts that an ordinary person is not impaired. Kind of like alcohol. Actually, just like alcohol. So now, because there are legal and practical obstacles to doing blood draws on everyone suspected of use, we need a THC breathalyzer that is sensitive enough to not only detect it, but also to quantify the concentration found. And because there is a precedent for having drivers use an alcohol breathalyzer, there are no issues with using it in roadside stops, as long as it is reliable enough to stand up to legal scrutiny in court as far as it’s accuracy and repeatability.
To summarize, at the present time the only acceptable test result is zero. Once it’s legalized the courts will need to establish a go/no go criteria, and they will need a device to measure to that standard. This is one such device.
Post number 26861
This might be similar to Taser, but there is a very limited market for Taser in the workplace (think of construction or manufacturing type environments), and few parents buy Tasers to keep their teenage kids in line. Also I've never seen a Taser on an ignition interlock for preventing impaired driving, but as I think of it, that might be one for me to patent.
I did a quick google search, there are about 400K police cars in the USA. I have previously posted my conservative estimate for potential sales, and a spitball of what I think the stock is worth based on potential sales. I feel that I was very conservative. Take a look at Taser or Gopro for what can happen to technology based company stock prices.
TMO paid 10x annual revenues for Mesa biotech. There are around 400,000 police cars in the USA (google search gave me that number). If Blozf puts a unit in 25% of them a year at $2000 a copy that is annual revenues of $200M. That puts thumbnail valuation at around $2B, or ~ $19/share. That is only considering the US market, and only considering law enforcement. Add workplace screening for manufacturing, process and construction industries, and then factor in those “other” markets, i.e. the rest of the world.
Those numbers are mine, and the assumptions and math are mine. I have a very positive outlook for this effort, I’ve been on and off this train for six plus years, it looks like it may finally be moving for real.
I wish the best of luck to all, especially those who have been watching this cake bake for over half a decade.
First to market with an OK product is fine, until the better device comes along. Kinda like the old saying from the pizza box, “you’ve tried the rest, now try the best”, or as we used to say, “you’ve tried the rest, we’re open”.
As far as the laws, I agree the laws will change, but I do not think they will specify that “brand X” device must be used to measure THC in breath by the side of the road, and nothing else. Again, if a threshold is established, the device is almost irrelevant, but if the first device is found to have a compromising aspect (easily thrown out in court), it may be suitable for determining probable cause to require a blood draw, but will be phased out when a better technology that is harder to dispute in court is made available.
You do your due diligence, I’ll do mine.
Take a look at the technology used by Hound vs Cannabix. Hound is using wet chemical analysis, where the breath sample is passed over some solution and then it is mixed with another solution and then a colored light is shined through it and the shade of some other color is measured on the other side. I’ve got a basic understanding of chemical lab analysis and I could poke a hundred holes in that process if I were a DUI lawyer. The process is too dependent on the stability of consumables (chemicals) in widely varying environments (inside a police car in all weather). Chemicals degrade, they expire, the sensor for the colored light reading at the end of the process will need to have its calibration verified, etc.
Cannabix is using either FAIMS or microfluidics technology, or a combination of the two. FAIMS is an electromagnetic device, easy calibration there. Microfluidics can be verified with a calibration gas to ensure they are still working properly. From a purely technical perspective I give an A+ to the folks at Cannabix for developing a new application for existing technologies that work. Hound gets a C+ for applying what they learned in basic analytical chemistry lab, they don’t fail, but they aren’t the star of the class.
With that said, we need to remember back to the trade show several years ago when the empty case for a new “pot breathalyzer” was unveiled. Lots of press, things looked great until a reporter picked it up and saw it was empty. IMO, the idea was there, but they had zero idea how to execute until they ran into Dr. Yost and hooked up with University of Florida. Serendipity at it’s finest. With the new device completed, they need a few things to happen. First, get past the political turmoil that is rolling around the nation and get some unified direction on how the next four years are going to be. That should calm the markets. Second, they need to see positive results from the clinical testing that will start this year. Third, they need to see some interest in the device from Law Enforcement and the press - a 2 minute segment on a major news network during the second half of the 6:00 news would do the trick. Last, they need to have solid plans for manufacturing and sales. It’s a lot of work, and will also require a bit of luck as things move along, but stranger things have succeeded.
Owlstone is about disease detection, they are a competitor to Breathtec, or whatever that venture is called these days. Yost is the head of University of Florida's analytical chemistry department, I think that is his primary vocation. The other stuff is (are) sidelines, he will be on the board of advisors or directors if it is an application of his technology that he has interest in advancing. I don't see him playing one venture against another, but hey, I've been wrong many times before. I have faith in his ability to oversee the Cannabix application of his technology based on his prior record of successes. There are many potential pitfalls, some in their control, many out of their control, that can hang things up. We'll see eventually.
Do your own investment research, make your own investment decisions, and don't trust what you read on internet forums. Those are my standard caveats.
Testing for impairment may indeed be impossible, but testing for unmetabolized THC concentrations in blood via breath analysis may be very possible. As with alcohol, people are affected differently. At a set level, one person may be incoherent while another may be fully functional. But if either is above the level prescribed by law, they are not allowed to legally drive a car.
I see the same logic being applied to pot once a breathalyzer is on the market that has a proven track record of being able to determine THC concentration in blood via breath analysis. Harry Potter may smoke one joint and be so stoned he can't stand up, while Jeff Spicoli can hot box a pound of Maui's finest and be able to quote legal verses. But once the gov't has a tool to analyze, and sets a limit, if either is above the prescribed number they will not be permitted to legally drive a car until they are back below that level.
Looking at the particular tool in question, the FAIMS technology developed by Dr. Yost at the University of Florida has great promise. He has used this technology in the past to detect small molecules in gas samples. It is a matter of making that particular device reliable enough to withstand use "out in the wild", accurate enough to produce results that stand up in court, and scalable enough to be mass produced. Those three aspects are what I see as important. If they can hit all three, this has the potential to be absolutely huge. Do your own research, use your own judgement, and be wary of what you read on internet forums.
Notice the pictures showing pass/fail. This is the one for the workplace and for parents to buy to see if their kids are smoking. The pass/fail will work in the workplace, as most that care about THC have a threshold of zero. It is also acceptable for parents.
In my opinion a working unit on the street is good, even if it's a pass/fail unit. Law enforcement can use it as the basis of probable cause to get a warrant for a blood draw as well. All good things in my book.
Perfection is the enemy of good enough. Time to get a good enough pass/fail detector on the market and sell a bunch of them.
Tell me, oh wise one, how do I invest in hound labs?
You do your analysis, I'll do mine.
I'm focusing on BLOZF because I have read what the various companies have published explaining how their devices work, and I think that theirs is technically viable. Regarding the hound, I can spend $100 million dollars and have little to show for it, just give me a chance! I have explained my questions about their approach before, but I'll repeat. Hound uses a chemical process to modify the breath sample so it will glow when exposed to UV light, then they measure the intensity of the glow and determine the concentration of THC. The chemical process they use is broadly characterized as a "wet chemical analysis". They use chemical reagents (solutions) to react with the sample, which change the sample. Chemical reactions are dependent on the strength of the solutions used, and the solutions generally change over time as the solutions age. They degrade. This is affected by heat, cold, etc. So a set of solutions in the trunk of a police car could be questioned. As in during court hearings. Then they expose it to UV light. The strength of the light is important. ANY deviation will affect the end result. These are all aspects which can and will be challenged in court, and any college student who has taken a 200 level analytical chemistry class can make the valid argument which introduces a reasonable doubt. That is why I have little regard for hound and their approach to the problem.
As far as our pals at BLOZF, what I have found on their technology is that it is basically a tuned mass spectrometer, which seems to be the agreed upon "gold standard" of detection.
BLOZF could do a better job of pushing the application engineering along, and communicating regularly with shareholders via meaningful press releases. I'm patient. First to market is good, but first to market with a working device is better.
They can study the technology based on what is published - no hands-on needed. Not saying how valid the results of said study will be, but hey, for a few million I'll do a study on global warming and how blowing up the moon will mitigate the tidal impacts of rising sea levels due to polar ice cap melt. I can even say what the results of my study will be - further study is required.
So they can study all they like. Their nanotechnology stuff is actually the first valid approach I've heard of besides FAIMS. It will come down to accuracy, reliability, repeatability, and unit cost of the equipment and unit cost of each use. Time will tell. I've been riding this mule for years, I'm patient. But it's time to start showing tangible goods.
I agree, and I think the reason they haven’t done that for saliva testing is because it is not a reliable correlation from person to person, or day to day. Breath is, but it’s very difficult and decays rapidly. So a saliva test that indicates presence would need to be used as probable cause to do a blood draw and immediate lab analysis. Once the breath analysis technology is there, I see a number limit for THC in blood being established quickly.
Agreed. Detection is first. It is like engineering, it is either there or it isn’t. Impairment is down the road. That is for the medical guys and the lawyers to figure out. Impairment is like tax law. Start out with a number and manipulate it until you get the desired result. Not the scope of work for the manufacturer if a detection device.
You can glean what you like, I'll read what I see. The heart of the device (the FAIMS detector) is unique and nobody else has it. Will a better mousetrap beat Cannabix to market? Quite possibly, if they don't get their shit together. Where are they now? I do not know. You do not know. They know, but are keeping their info close to the vest.
In the end we are all waiting for the stock price to spike up so we can cash in our holdings and move on to the next opportunity. Everyone's timeline is different, everyone's tolerance for watching a rollercoaster price is different. With the market in pretty crappy condition the last few months my tolerances are higher to put up with their silence, as other investments are just as risky with less potential for acceptable returns. If the market starts screaming again, I may take a different approach. We'll see.
I took a quick look at the rejection letter and one thing that was obvious to me was that it was very critical of the breath collection device but said nothing bad about the actual detection / analysis device. To me the letter is a distraction. So there is nothing special about the collection device, no big deal. Use a red rubber balloon and get on with it.
Probably a confidentiality agreement in place which prevents them from disclosing cannabix as a client.
I have to think they have been conducting in- house testing for some time now. The device looks for some very specific molecules and provides concentration levels for them. Interpretation of those levels is where the lawyers get involved and is beyond the scope of testing a device that detects. I really think that people have been over complicating the interpretation part as well. To uphold a legal standard there needs to be a measurement taken, and the results compared to a standard. If the measured number is above a threshold they will be charged with something. Below and they are free to go. What the standard is and how it is applied is to be wrestled out between doctors, lawyers, judges, scientists, engineers and any other clowns who jump in the ring. Reliably and repeatably measuring concentration of specific molecules in breath samples is what this device must do. And it’s time these folks finish their R&D effort and show us and the world a complete functioning device. One will do. A small production batch of a hundred released for real world field testing would be even better. I’ve been waiting on this thing too long, I’ll settle for one.
They paid an expediting fee for patent examination. This must mean something. If the examination takes a few months and then the patent is issued, units can be distributed for validation testing with some protection from copying by competitors.
In Canada, there is a separate step of requesting examination which must be done within 5 years of the filing date of the application in Canada that starts the examination process.
Once the application is examined by patent examiner, it is typical that the patent examiner will issue at least one examination report or office action. An office action is a detailed report that outlines objections to the form of the application or the form or substantive of the patent claims. It usually includes citations of prior art, often prior patents and published patent applications, that the examiner alleges to be relevant to the patentability of what’s claimed in the subject patent application.
An office action is usually received by the applicant within 24 months of filing a regular patent application in the United States or within 24 months of requesting examination in Canada.
In the United States, an applicant must respond to an office action within 3 months of its mailing date. This deadline is extendable by one, two or three months upon payment of the applicable extension fee which rises which each additional month.
In Canada, an applicant must typically respond to an office action within 6 months of the date of the examiner's report. The response may include arguments against the objections made or amendments to the patent application with remarks as to why the amended application complies with the applicable requirements. If a good faith response to an office action is not filed within the prescribed timeframe, the patent application will be abandoned.
Upon reviewing the applicant’s response, if the examiner accepts that the amendments and/or arguments overcome the outlined objections and no further objections are made, then the patent application will proceed to the allowance phase.
If the examiner does not accept that the amendments and/or arguments overcome the objections, the examiner will issue a further office action. In this second office action, the examiner may raise new objections in addition to repeating previous objections if they are still applicable. The patent applicant then has a further opportunity to respond with amendments and/or arguments.
In the United States, this second office action is typically designated a final office action. For a final office action, a request for continued examination with a fee may need to be made to continue with the examination process if an acceptable amendment and response cannot be made which does not require the patent examiner to carry out a further search of prior art documents.
I agree that all necessary evidence will be collected at the time of the stop. Beyond that both of us are just hypothesizing. We won’t know until they actually tell us something of substance about how these components work together.
My take is they use a dumbed down FAIMS unit at the roadside to do a quick "yes or no" for presence of THC. If no, all good. If yes, back to station for further analysis of SAME SAMPLE. This capability is not something that anyone else has. If a driver slobbers positive by roadside, the concentrations will have changed by the time they get him (or her) in for a blood draw to confirm. The slobber sample has enzymes in it that are breaking down anything in the sample so it's useless.
The locals can either buy the full blown FAIMS unit for back at the cop shop, or can send in samples for lab analysis. Either way it is the same preserved sample as taken at time of the traffic stop.
Time will tell. Let's see this thing roll out and orders roll in.